Display options
Cite
Chappell MC, Marshall AC, Alzayadneh EM, et al. Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways. Front Endocrinol (Lausanne). 2014;4:201doi: 10.3389/fendo.2013.00201.
Chappell, M. C., Marshall, A. C., Alzayadneh, E. M., Shaltout, H. A., & Diz, D. I. (2014). Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways. Frontiers in endocrinology, 4201. https://doi.org/10.3389/fendo.2013.00201
Chappell, Mark C, et al. "Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways." Frontiers in endocrinology vol. 4 (2014): 201. doi: https://doi.org/10.3389/fendo.2013.00201
Chappell MC, Marshall AC, Alzayadneh EM, Shaltout HA, Diz DI. Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways. Front Endocrinol (Lausanne). 2014 Jan 09;4:201. doi: 10.3389/fendo.2013.00201. PMID: 24409169; PMCID: PMC3886117.
Copy Download .nbib Format: NLM
Share it on

Front Endocrinol (Lausanne). 2014 Jan 09;4:201. doi: 10.3389/fendo.2013.00201.

Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.

Frontiers in endocrinology

Mark C Chappell, Allyson C Marshall, Ebaa M Alzayadneh, Hossam A Shaltout, Debra I Diz

Affiliations

  1. The Hypertension and Vascular Research Center, Wake Forest University School of Medicine , Winston-Salem, NC , USA.
  2. The Hypertension and Vascular Research Center, Wake Forest University School of Medicine , Winston-Salem, NC , USA ; Department of Obstetrics and Gynecology, Wake Forest University School of Medicine , Winston-Salem, NC , USA ; Department of Pharmacology and Toxicology, School of Pharmacy, Alexandria University , Alexandria , Egypt.

PMID: 24409169 PMCID: PMC3886117 DOI: 10.3389/fendo.2013.00201

Abstract

The renin-angiotensin-system (RAS) constitutes an important hormonal system in the physiological regulation of blood pressure. Indeed, dysregulation of the RAS may lead to the development of cardiovascular pathologies including kidney injury. Moreover, the blockade of this system by the inhibition of angiotensin converting enzyme (ACE) or antagonism of the angiotensin type 1 receptor (AT1R) constitutes an effective therapeutic regimen. It is now apparent with the identification of multiple components of the RAS that the system is comprised of different angiotensin peptides with diverse biological actions mediated by distinct receptor subtypes. The classic RAS can be defined as the ACE-Ang II-AT1R axis that promotes vasoconstriction, sodium retention, and other mechanisms to maintain blood pressure, as well as increased oxidative stress, fibrosis, cellular growth, and inflammation in pathological conditions. In contrast, the non-classical RAS composed of the ACE2-Ang-(1-7)-Mas receptor axis generally opposes the actions of a stimulated Ang II-AT1R axis through an increase in nitric oxide and prostaglandins and mediates vasodilation, natriuresis, diuresis, and oxidative stress. Thus, a reduced tone of the Ang-(1-7) system may contribute to these pathologies as well. Moreover, the non-classical RAS components may contribute to the effects of therapeutic blockade of the classical system to reduce blood pressure and attenuate various indices of renal injury. The review considers recent studies on the ACE2-Ang-(1-7)-Mas receptor axis regarding the precursor for Ang-(1-7), the intracellular expression and sex differences of this system, as well as an emerging role of the Ang1-(1-7) pathway in fetal programing events and cardiovascular dysfunction.

Keywords: ACE; ACE2; Ala1-Ang-(1–7); Ang-(1–7); Mas receptor; Mas-related receptor D; fetal programing

References

  1. Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1392-9 - PubMed
  2. Science. 1971 Jun 11;172(3988):1138-9 - PubMed
  3. Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1374-84 - PubMed
  4. Hypertension. 2013 Jan;61(1):253-8 - PubMed
  5. Cancer Res. 2010 Nov 1;70(21):8319-28 - PubMed
  6. J Steroid Biochem Mol Biol. 1991;40(4-6):511-5 - PubMed
  7. Peptides. 2012 Apr;34(2):380-8 - PubMed
  8. Endocrinology. 2002 Nov;143(11):4455-63 - PubMed
  9. Hypertension. 2010 Jan;55(1):90-8 - PubMed
  10. Circ Res. 2013 Jan 18;112(2):224-6 - PubMed
  11. Circ Res. 2013 Apr 12;112(8):1104-11 - PubMed
  12. Clin Sci (Lond). 2012 Sep;123(6):333-46 - PubMed
  13. J Biol Chem. 2010 Dec 31;285(53):41935-46 - PubMed
  14. Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R518-30 - PubMed
  15. Acta Physiol Hung. 2002;89(4):427-38 - PubMed
  16. Endocrinology. 1992 Jul;131(1):374-80 - PubMed
  17. Hypertension. 2009 Feb;53(2):404-8 - PubMed
  18. Am J Physiol Regul Integr Comp Physiol. 2009 Feb;296(2):R309-17 - PubMed
  19. J Biol Chem. 2005 Aug 26;280(34):30113-9 - PubMed
  20. J Biol Chem. 1989 Oct 5;264(28):16518-23 - PubMed
  21. Hypertension. 1998 Sep;32(3):496-502 - PubMed
  22. J Hypertens Suppl. 1984 Dec;2(3):S271-3 - PubMed
  23. Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2614-8 - PubMed
  24. Cancer Sci. 2008 Feb;99(2):214-20 - PubMed
  25. Am J Physiol Renal Physiol. 2006 May;290(5):F1270-5 - PubMed
  26. Hypertension. 2002 Mar 1;39(3):790-3 - PubMed
  27. Exp Physiol. 2008 May;93(5):694-700 - PubMed
  28. Diabetes. 2010 Feb;59(2):529-38 - PubMed
  29. Pharmacol Rev. 2007 Sep;59(3):251-87 - PubMed
  30. PLoS One. 2013 Jul 01;8(7):e69234 - PubMed
  31. Physiol Genomics. 2011 Jul 14;43(13):829-35 - PubMed
  32. Gend Med. 2012 Feb;9(1):21-32 - PubMed
  33. Am J Physiol Renal Physiol. 2010 Nov;299(5):F983-90 - PubMed
  34. Biol Cell. 2012 Feb;104(2):70-83 - PubMed
  35. Am J Physiol Renal Physiol. 2006 Jun;290(6):F1497-506 - PubMed
  36. J Cardiovasc Pharmacol. 2012 Aug;60(2):150-7 - PubMed
  37. Hypertension. 1992 Jun;19(6 Pt 2):692-6 - PubMed
  38. Nat Med. 2005 Aug;11(8):867-74 - PubMed
  39. Hypertension. 2005 May;45(5):960-6 - PubMed
  40. Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H699-705 - PubMed
  41. Hypertension. 2005 Aug;46(2):333-40 - PubMed
  42. Hypertension. 2003 Oct;42(4):781-6 - PubMed
  43. Int J Hypertens. 2012;2012:690785 - PubMed
  44. Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H541-7 - PubMed
  45. Curr Heart Fail Rep. 2011 Sep;8(3):176-83 - PubMed
  46. J Hypertens. 1996 Aug;14(8):961-8 - PubMed
  47. Biochem Biophys Res Commun. 2009 Jun 26;384(2):149-54 - PubMed
  48. J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1135-48 - PubMed
  49. Peptides. 2012 Jun;35(2):190-5 - PubMed
  50. Braz J Med Biol Res. 1999 Apr;32(4):373-81 - PubMed
  51. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):677-83 - PubMed
  52. J Physiol. 2003 Jun 15;549(Pt 3):929-35 - PubMed
  53. Am J Physiol Regul Integr Comp Physiol. 2010 Sep;299(3):R793-803 - PubMed
  54. Acta Physiol (Oxf). 2012 Oct;206(2):150-6 - PubMed
  55. Am J Physiol Cell Physiol. 2008 Nov;295(5):C1169-74 - PubMed
  56. Placenta. 2011 Feb;32(2):134-9 - PubMed
  57. J Biol Chem. 1993 Nov 25;268(33):24543-6 - PubMed
  58. Hypertension. 1998 Jan;31(1 Pt 2):356-61 - PubMed
  59. J Biol Chem. 2002 Apr 26;277(17):14838-43 - PubMed
  60. Cell Mol Neurobiol. 2012 Nov;32(8):1353-65 - PubMed
  61. Hypertension. 2010 Oct;56(4):658-66 - PubMed
  62. Am J Physiol Renal Physiol. 2005 Feb;288(2):F420-7 - PubMed
  63. Hypertension. 1998 Jan;31(1 Pt 2):362-7 - PubMed
  64. Circ Res. 2013 Jan 18;112(2):236-45 - PubMed
  65. FASEB J. 2011 Sep;25(9):2987-95 - PubMed
  66. Hypertension. 2011 Feb;57(2):314-22 - PubMed
  67. J Pharmacol Exp Ther. 1998 Nov;287(2):567-77 - PubMed
  68. J Cell Sci. 2008 Feb 1;121(Pt 3):249-53 - PubMed
  69. Int J Hypertens. 2012;2012:192567 - PubMed
  70. Hypertension. 2011 Mar;57(3):355-62 - PubMed
  71. Am J Physiol. 1997 Dec;273(6):R1908-15 - PubMed
  72. Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):479-88 - PubMed
  73. Hypertension. 2010 Jan;55(1):166-71 - PubMed
  74. Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R1-R10 - PubMed
  75. Endocrinology. 1992 Jun;130(6):3641-9 - PubMed
  76. Hypertension. 2012 Feb;59(2):453-8 - PubMed
  77. Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H763-71 - PubMed
  78. Am J Physiol Regul Integr Comp Physiol. 2009 Jul;297(1):R111-5 - PubMed
  79. Hypertension. 1999 Oct;34(4 Pt 1):534-8 - PubMed
  80. Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):297-302 - PubMed
  81. Hypertension. 1994 Apr;23(4):439-49 - PubMed
  82. Clin Sci (Lond). 2012 Sep;123(5):273-84 - PubMed
  83. Circ Res. 1995 May;76(5):693-700 - PubMed
  84. Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R494-509 - PubMed
  85. J Pharmacol Exp Ther. 1998 Mar;284(3):799-805 - PubMed
  86. Can J Physiol Pharmacol. 2006 Mar-Apr;84(3-4):403-22 - PubMed
  87. PLoS One. 2011;6(12):e28501 - PubMed
  88. Hypertension. 2000 Jan;35(1 Pt 2):348-52 - PubMed
  89. Peptides. 2014 Feb;52:74-81 - PubMed
  90. Acta Physiol Scand. 2004 Aug;181(4):537-42 - PubMed
  91. Am J Physiol Cell Physiol. 2013 May 15;304(10):C945-53 - PubMed
  92. J Biol Chem. 2004 Feb 27;279(9):7901-8 - PubMed
  93. Compr Physiol. 2012 Oct;2(4):2733-52 - PubMed
  94. Genes Cells. 2005 Dec;10(12):1139-51 - PubMed
  95. Hypertension. 2013 Nov;62(5):879-85 - PubMed
  96. Biochem Biophys Res Commun. 2006 Dec 1;350(4):1026-31 - PubMed
  97. Hypertension. 2006 Mar;47(3):502-8 - PubMed
  98. J Cell Sci. 2009 Jul 15;122(Pt 14):2337-50 - PubMed
  99. Hypertension. 2007 Sep;50(3):579-84 - PubMed
  100. Int J Hypertens. 2012;2012:493129 - PubMed
  101. Biochem J. 2004 Oct 1;383(Pt 1):45-51 - PubMed
  102. Nephrol Dial Transplant. 2009 Jun;24(6):1766-73 - PubMed
  103. Biol Sex Differ. 2010 Nov 05;1(1):6 - PubMed
  104. Hypertension. 2010 Feb;55(2):207-13 - PubMed
  105. Hypertension. 2011 Mar;57(3):620-6 - PubMed
  106. Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1220-6 - PubMed
  107. Hypertension. 2000 Jan;35(1 Pt 2):480-3 - PubMed
  108. Am J Physiol Regul Integr Comp Physiol. 2005 Feb;288(2):R539-46 - PubMed
  109. Brain Res. 1999 Dec 18;851(1-2):261-5 - PubMed
  110. J Biol Chem. 2011 Mar 18;286(11):8977-87 - PubMed
  111. Am J Physiol Renal Physiol. 2007 Jan;292(1):F82-91 - PubMed
  112. Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H801-10 - PubMed
  113. Pharmacol Rev. 2000 Sep;52(3):415-72 - PubMed
  114. PLoS One. 2013 Apr 30;8(4):e62833 - PubMed
  115. J Renin Angiotensin Aldosterone Syst. 2013 Dec;14(4):290-8 - PubMed
  116. Clin Sci (Lond). 2000 Feb;98(2):137-42 - PubMed
  117. Am J Physiol Renal Physiol. 2006 Jun;290(6):F1382-90 - PubMed
  118. Hypertension. 2002 Nov;40(5):729-34 - PubMed
  119. Int J Hypertens. 2012;2012:147825 - PubMed
  120. J Mol Med (Berl). 2008 Jun;86(6):615-21 - PubMed
  121. J Am Soc Nephrol. 2012 Jul;23(7):1181-9 - PubMed
  122. Hypertension. 1993 Oct;22(4):496-501 - PubMed
  123. J Cell Physiol. 2008 Jul;216(1):234-44 - PubMed
  124. PLoS One. 2012;7(4):e34747 - PubMed
  125. Am J Physiol Cell Physiol. 2008 Apr;294(4):C1034-45 - PubMed
  126. J Cardiovasc Pharmacol. 1994 Apr;23(4):640-6 - PubMed
  127. Br J Pharmacol. 2012 Mar;165(5):1390-400 - PubMed
  128. Am J Physiol Regul Integr Comp Physiol. 2013 Oct 1;305(7):R679-88 - PubMed
  129. Biochem Biophys Res Commun. 1995 Aug 4;213(1):66-73 - PubMed
  130. Hypertension. 2007 Oct;50(4):596-9 - PubMed
  131. J Endocrinol. 2013 Jan 18;216(2):R1-R17 - PubMed
  132. Hypertens Res. 2011 Dec;34(12):1257-62 - PubMed
  133. Exp Physiol. 2008 May;93(5):519-27 - PubMed
  134. J Physiol Pharmacol. 2010 Dec;61(6):679-82 - PubMed
  135. Circ Res. 2013 Oct 12;113(9):1087-1096 - PubMed
  136. Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1754-64 - PubMed
  137. Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L84-96 - PubMed
  138. Physiol Rev. 2006 Jul;86(3):747-803 - PubMed
  139. Gend Med. 2008;5 Suppl A:S65-75 - PubMed
  140. Adv Pharmacol. 2010;59:197-233 - PubMed
  141. Am J Physiol Renal Physiol. 2000 Nov;279(5):F841-50 - PubMed
  142. Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F600-11 - PubMed
  143. J Biol Chem. 2006 Jun 9;281(23):16058-67 - PubMed
  144. Peptides. 2013 Jun;44:25-31 - PubMed
  145. Can J Physiol Pharmacol. 2013 Jan;91(1):71-9 - PubMed

Publication Types

Grant support